ALCON INC (ALC) Stock
ALC has an Alpha Score of 41 out of 100 (weak), computed on Nov 6, 2026 from 3 of 4 sub-scores. 9 members of Congress disclosed 16 trades in ALC since 2019: 6 purchases and 9 sales, most recently Kevin Hern (sale, Aug 5, 2026). Its trailing P/E ratio is 45.0 and its net margin 5.9% (key statistics as of Nov 4, 2026).
What is ALC's Alpha Score?
How it works →Alpha Score of 41 reflects weak overall profile with strong momentum, poor value, weak quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Nov 6, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded ALCON INC (ALC)?
Most recent: Kevin Hern (sale, Aug 5, 2026); records start Apr 11, 2019.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Kevin Hern R-OK · House | 2026-08-05 | sale | $1k – $15k |
| Alan Armstrong R-OK · Senate | 2026-03-30 | purchase | $1k – $15k |
| Josh Gottheimer D-NJ · House | 2026-03-12 | sale | $1k – $15k |
| Julie Johnson D-TX · House | 2025-03-03 | sale | $1k – $15k |
| Josh Gottheimer D-NJ · House | 2024-06-21 | partial sale | $1k – $15k |
| Dan Goldman D-NY · House | 2023-07-10 | sale | $15k – $50k |
| Peter Meijer R-MI · House | 2021-02-17 | sale | $15k – $50k |
| Josh Gottheimer D-NJ · House | 2020-10-16 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
See all ALC political trades →What are ALC's key statistics?
Key statistics as of Nov 4, 2026
How does ALC's valuation compare with the Healthcare sector?
| Metric | ALC | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 45.0 | 28.8 | 111 |
| Net margin | 5.92% | 4.31% | 164 |
| Return on equity | 2.93% | 5.47% | 185 |
| Dividend yield (payers) | 0.32% | 1.59% | 55 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 7, 2026). P/E excludes loss-making companies.
ALC price chart
Powered by TradingViewWhat does ALCON INC do?
Alcon Inc. is a leading global vision care company specializing in the development, manufacture, and marketing of surgical equipment, devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. Originally founded in 1945 and headquartered in Geneva, Switzerland, it operated as a subsidiary of Novartis for nine years before becoming an independent public company in April 2019. Alcon Inc. functions through two primary segments: Vision Care, which includes contact lenses, lens care solutions, and ocular health products under brands like Dailies, Total1, and Air Optix, capturing about one-fourth of the U.S. contact lens market; and Surgical, featuring intraocular lenses, ophthalmic surgical equipment, and consumables such as the Centurion phacoemulsification device for cataract surgeries and IOLs like PanOptix and Vivity. With approximately 25,599 employees, Alcon Inc. maintains one of the largest installed bases of eye surgical equipment worldwide, playing a pivotal role in the healthcare sector, particularly in medical instruments and supplies, by advancing eye health innovations and supporting ophthalmologists and consumers globally.